Tumor Biology

, Volume 36, Issue 12, pp 9525–9535 | Cite as

Effect of ERCC8 tagSNPs and their association with H. pylori infection, smoking, and alcohol consumption on gastric cancer and atrophic gastritis risk

  • Jing-jing Jing
  • Li-ping Sun
  • Qian Xu
  • Yuan Yuan
Research Article


Excision repair cross-complementing group 8 (ERCC8) plays a critical role in DNA repair. Genetic polymorphisms in ERCC8 may contribute to the risk of cancer development. We selected tag single nucleotide polymorphisms (tagSNPs) in Chinese patients from the HapMap database to investigate associations with gastric cancer and its precursors. Genomic DNA was extracted from 394 controls, 394 atrophic gastritis, and 394 gastric cancer cases in northern Chinese patients, and genotypes were identified using the Sequenom MassARRAY system. We found that the ERCC8 rs158572 GG+GA genotype showed a 1.651-fold (95 % confidence interval (CI) = 1.109–2.457, P = 0.013) increased risk of gastric cancer compared with the AA genotype, especially in diffuse type. Stratified analysis comparing the common genotype revealed significantly increased gastric cancer risk in males and individuals older than 50 years with rs158572 GA/GG/GG+GA genotypes, while individuals older than 50 years with rs158916 CT/CC+CT genotypes were less susceptible to atrophic gastritis. Haplotype analysis showed that the G-T haplotype was associated with increased risk of gastric cancer. Statistically significant interactions between the two ERCC8 tagSNPs and Helicobacter pylori infection were observed for gastric cancer and atrophic gastritis risk (P < 0.05). Smokers and drinkers with ERCC8 rs158572 GG+GA genotype were more susceptible to gastric cancer compared with non-smokers and non-drinkers homozygous for AA. Our findings suggested that ERCC8 rs158572 and rs158916, alone or together with environmental factors, might be associated with gastric cancer and atrophic gastritis susceptibility. Further validation of our results in larger populations along with additional studies evaluating the underlying molecular function is required.


ERCC8 TagSNP Gastric cancer Atrophic gastritis Susceptibility 



This work is supported by grants from the National Key Basic Research Program of China (973 Program Ref No.2010CB529304) and the National Natural Science Foundation of China (Ref No.31200968).

Authors’ contributions

YY conceived and designed the experiments and revised the manuscript. JJ and QX performed the experiments. JJ and LS analyzed the data. LS and QX collected the serum/biopsy samples. YY contributed the reagents/materials/analysis tools. JJ and YY wrote the paper.

Conflicts of interest



  1. 1.
    Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–36.CrossRefPubMedGoogle Scholar
  2. 2.
    Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull. 2008;85:87–100.CrossRefPubMedGoogle Scholar
  4. 4.
    Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42:211–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Palli D, Polidoro S, D’Errico M, Saieva C, Guarrera S, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25:569–75.CrossRefPubMedGoogle Scholar
  6. 6.
    Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85.CrossRefPubMedGoogle Scholar
  7. 7.
    Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874–97.CrossRefPubMedGoogle Scholar
  8. 8.
    Henning KA, Li L, Iyer N, McDaniel LD, Reagan MS, et al. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell. 1995;82:555–64.CrossRefPubMedGoogle Scholar
  9. 9.
    Boraz RA. Cockayne’s syndrome: literature review and case report. Pediatr Dent. 1991;13:227–30.PubMedGoogle Scholar
  10. 10.
    Laugel V, Dalloz C, Durand M, Sauvanaud F, Kristensen U, et al. Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum Mutat. 2010;31:113–26.CrossRefPubMedGoogle Scholar
  11. 11.
    Fousteri M, Mullenders LH. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008;18:73–84.CrossRefPubMedGoogle Scholar
  12. 12.
    Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22–33.CrossRefPubMedGoogle Scholar
  13. 13.
    Costa RM, Chigancas V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie. 2003;85:1083–99.CrossRefPubMedGoogle Scholar
  14. 14.
    Stevnsner T, Muftuoglu M, Aamann MD, Bohr VA. The role of Cockayne syndrome group B (CSB) protein in base excision repair and aging. Mech Ageing Dev. 2008;129:441–8.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, et al. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell. 2003;113:357–67.CrossRefPubMedGoogle Scholar
  16. 16.
    Fousteri M, Vermeulen W, van Zeeland AA, Mullenders LH. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol Cell. 2006;23:471–82.CrossRefPubMedGoogle Scholar
  17. 17.
    Groisman R, Kuruoka I, Chevallier O, Gaye N, Magnaldo T, et al. CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors in the Cockayne syndrome. Genes Dev. 2006;20:1429–34.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    D’Errico M, Parlanti E, Teson M, Degan P, Lemma T, et al. The role of CSA in the response to oxidative DNA damage in human cells. Oncogene. 2007;26:4336–43.CrossRefPubMedGoogle Scholar
  19. 19.
    Frosina G. The current evidence for defective repair of oxidatively damaged DNA in Cockayne syndrome. Free Radic Biol Med. 2007;43:165–77.CrossRefPubMedGoogle Scholar
  20. 20.
    Nardo T, Oneda R, Spivak G, Mortier L, Thomas P, et al. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc Natl Acad Sci U S A. 2009;106:6209–14.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, et al. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer. Cancer. 2012;118:689–97.CrossRefPubMedGoogle Scholar
  22. 22.
    Guillem VM, Cervantes F, Martínez J, Alvarez-Larrán A, Collado M, et al. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia. Am J Hematol. 2010;85:482–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Tu H, Sun L, Dong X, Gong Y, Xu Q, et al. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scand J Gastroenterol. 2014;49(3):259–66.CrossRefPubMedGoogle Scholar
  24. 24.
    Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMedGoogle Scholar
  25. 25.
    Hamilton S, Aaltonen L. World Health Organization classification of tumours. Pathology and genetics of turnouts of the digestive system. Lyon: IARC Press; 2000. p. 237–40.Google Scholar
  26. 26.
    Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMedGoogle Scholar
  27. 27.
    Barrett JC. Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc. 2009;4:pdb ip71.Google Scholar
  28. 28.
    Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis. 2010;29:907–11.CrossRefPubMedGoogle Scholar
  29. 29.
    Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Li Z, Zhang Z, He Z, Tang W, Li T, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHE-sis Cell Res. 2009;19:519–23.CrossRefPubMedGoogle Scholar
  31. 31.
    Trzyna E, Duleba M, Faryna M, Majka M. Regulation of transcription in cancer. Front Biosci (Landmark Ed). 2012;17:316–30.CrossRefGoogle Scholar
  32. 32.
    Crepieux P, Leprince D, Flourens A, Albagli O, Ferreira E, et al. The two functionally distinct amino termini of chicken c-ets-1 products arise from alternative promoter usage. Gene Expr. 1993;3:215–25.PubMedGoogle Scholar
  33. 33.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  34. 34.
    Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467–77.CrossRefPubMedGoogle Scholar
  35. 35.
    Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20(4):651–74.CrossRefPubMedGoogle Scholar
  36. 36.
    Zabaleta J. Multifactorial etiology of gastric cancer. Methods Mol Biol. 2012;863:411–35.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010;14:302–8.PubMedGoogle Scholar
  38. 38.
    Sankari SL, Masthan KM, Babu NA, Bhattacharjee T, Elumalai M. Apoptosis in cancer—an update. Asian Pac J Cancer Prev. 2012;13:4873–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Brooks PJ. DNA damage, DNA repair, and alcohol toxicity—a review. Alcohol Clin Exp Res. 1997;21:1073–82.PubMedGoogle Scholar
  40. 40.
    Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3:733–44.CrossRefPubMedGoogle Scholar
  41. 41.
    Joenje H. Metabolism: alcohol, DNA and disease. Nature. 2011;475:45–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A. 2011;108:14944–9.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Jing-jing Jing
    • 1
    • 2
  • Li-ping Sun
    • 1
    • 2
  • Qian Xu
    • 1
    • 2
  • Yuan Yuan
    • 1
    • 2
  1. 1.Tumor Etiology and Screening Department of Cancer Institute and General SurgeryThe First Affiliated Hospital of China Medical UniversityShenyang CityChina
  2. 2.Key Laboratory of Cancer Etiology and Prevention, Liaoning Provincial Education DepartmentChina Medical UniversityShenyangChina

Personalised recommendations